Angel & Family Offices Investing in Healthcare · September 3, 2026

Program Description

For most healthcare startups, raising the first institutional dollars is one of the most challenging and consequential steps on the path to commercialization. A compelling technology and polished pitch are rarely enough. Investors are looking for experienced leadership, a credible strategy, and evidence that a company is ready to create value.

As the venture capital landscape continues to evolve, angel investors and family offices are playing an increasingly important role in financing healthcare innovation. Many family offices have become sophisticated direct investors, providing not only capital but also strategic guidance, industry relationships, and long-term perspectives that can accelerate company growth.

Join NEHEN for an engaging discussion featuring experienced investors and entrepreneurs who will share what they look for when evaluating opportunities, how investment decisions are made, and how founders can successfully position their companies for funding.

Discussion Topics

What we'll cover.

The expanding role of angel investors and family offices in healthcare investing
How today's investment environment is changing fundraising strategies
What investors look for beyond the pitch deck
Building relationships before you need capital
Positioning your company to attract the right investors
Determining the right financing strategy for your stage of growth
Common fundraising mistakes; and how to avoid them
Creating long-term value while aligning founder and investor expectations

Following the panel discussion, attendees will have the opportunity to participate in an interactive Q&A and network with executives, entrepreneurs, investors, and advisors from across the healthcare innovation ecosystem.

Panel

The speakers.

Moderator

John Hession

Advisory Board · Hub Angels Investment Group, Fund VII

John has been an emerging company business attorney for four decades and an angel investor for a quarter century. He is now an investor in Hub Angels Fund VII and serves on the Fund's Advisory Board and diligence teams. Over his career, John has worked with more than 400 emerging companies across life sciences, healthcare services, and medical devices, helping to structure over $10Bn in private capital, 25 public offerings, and approximately 275 acquisitions ranging in size from $1.0Mn to $4.2Bn. He serves on the Board of Mass Biomedical Initiative and Charles River Center, an autism nonprofit.

Panelist

Josko Silobrcic, MD, MPH, MS

Venture Partner · Hub Angels Investment Group LLC

Dr. Silobrcic is a Venture Partner at Hub Angels Investment Group LLC, focused on healthcare services, MedTech, medical devices, and infrastructure tools for biotech. With over thirty years of professional experience at the forefront of healthcare, Josko has served as a healthcare leader, C-suite executive, board member, advisor, and educator, and now represents Hub Angels as an active investor in healthcare-related companies. For nearly three decades, Hub Angels has been a leading investment fund in enterprise software, hardware, IoT, and materials sciences, and more recently in medical devices, software, AI-enhanced healthcare services, and other medical technologies. Hub Angels focuses on pre-seed and seed-stage investments in the Life Sciences sectors, investing prior to Series A financings.

Panelist

John Parker

Managing Partner · Springhood Ventures & Charles Hood Foundation

John founded the venture capital firm investing in pediatric and pediatric-first life science and healthcare companies, where unmet medical need, regulatory incentives, and capital-efficient models align to drive outsized returns and impact. The Charles H. Hood Foundation is one of the nation's oldest philanthropies dedicated exclusively to child health.

Panelist

John Hallinan

Chairman of the Board · MBI

John is Chairman of the Board of Directors at MBI (mbi.bio), the oldest nonprofit incubator in central Massachusetts, focused on drug discovery, diagnostics, therapeutics, medical devices, and other medical technologies. He worked with Locust Walk to create the Family Office BioForum, focused on educating ultra-high-net-worth investors and family offices on life sciences. Before retiring at the end of 2025, John was the Chief Development Officer at Danforth Advisors, working with mature companies across the Life Sciences spectrum. Previously, John was the Chief Business Officer at MassBio, the premier state-based trade organization for the Life Sciences industry, where he led the Innovation Services programs starting in 2012 and developed Entrepreneurs University, a program for early-stage founders. Before MassBio, John held CFO positions at several prominent companies in the life sciences and software industries.

Who Should Attend

Built for the people doing the raising, and the people writing the checks.

Healthcare and life sciences founders
CEOs and executive leadership teams
Angel and family office investors
Venture capital and private equity professionals
Board members and strategic advisors
Professionals supporting emerging healthcare companies

Beyond Venture Capital

Program Description

What we'll cover.

The speakers.

Built for the people doing the raising, and the people writing the checks.

September 3 · Foley Hoag Seaport West.